EP1206249A4 - Hydrodynamisch ausbalanciertes orales arzneistoffverabreichungssystem - Google Patents

Hydrodynamisch ausbalanciertes orales arzneistoffverabreichungssystem

Info

Publication number
EP1206249A4
EP1206249A4 EP00949840A EP00949840A EP1206249A4 EP 1206249 A4 EP1206249 A4 EP 1206249A4 EP 00949840 A EP00949840 A EP 00949840A EP 00949840 A EP00949840 A EP 00949840A EP 1206249 A4 EP1206249 A4 EP 1206249A4
Authority
EP
European Patent Office
Prior art keywords
hydrodynamically
delivery system
drug delivery
oral drug
balancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00949840A
Other languages
English (en)
French (fr)
Other versions
EP1206249A1 (de
Inventor
Naresh Talwar
John N Staniforth
Michael J Tobyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1206249A1 publication Critical patent/EP1206249A1/de
Publication of EP1206249A4 publication Critical patent/EP1206249A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP00949840A 1999-08-04 2000-08-01 Hydrodynamisch ausbalanciertes orales arzneistoffverabreichungssystem Withdrawn EP1206249A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/IB99/01386 1999-08-04
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system
PCT/IB2000/001083 WO2001010419A1 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Publications (2)

Publication Number Publication Date
EP1206249A1 EP1206249A1 (de) 2002-05-22
EP1206249A4 true EP1206249A4 (de) 2004-12-22

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00949840A Withdrawn EP1206249A4 (de) 1999-08-04 2000-08-01 Hydrodynamisch ausbalanciertes orales arzneistoffverabreichungssystem

Country Status (21)

Country Link
EP (1) EP1206249A4 (de)
JP (1) JP2003506400A (de)
CN (1) CN1376059A (de)
AP (1) AP2002002410A0 (de)
AU (2) AU5060499A (de)
BR (1) BR0012981A (de)
CA (1) CA2378468A1 (de)
CZ (1) CZ2002415A3 (de)
EA (1) EA200200126A1 (de)
HK (1) HK1047226A1 (de)
HR (1) HRP20020108A2 (de)
HU (1) HUP0202497A3 (de)
IL (1) IL147966A0 (de)
MX (1) MXPA02001272A (de)
NZ (1) NZ516959A (de)
OA (1) OA12003A (de)
PL (1) PL353321A1 (de)
SK (1) SK1832002A3 (de)
TR (1) TR200200467T2 (de)
WO (2) WO2001010405A1 (de)
ZA (1) ZA200200926B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
KR20040018394A (ko) 2001-07-04 2004-03-03 썬 파마슈티컬 인더스트리스 리미티드 위 정체 제어되는 약물 전달 계
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CN101005830B (zh) 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (de) * 2005-02-15 2006-08-16 Neuro3D Zusammensetzung enthaltend Ocaperidon
AU2006330526B2 (en) 2005-12-22 2012-09-27 Oakwood Laboratories, Llc Sublimable sustained release delivery system and method of making same
EP1886665A1 (de) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastroretentives Freisetzungssystem
US10888521B2 (en) * 2007-03-02 2021-01-12 Farnam Companies, Inc. Sustained release compositions using wax-like materials
BRPI0917444A2 (pt) 2008-08-15 2015-12-01 Depomed Inc composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
EP2329810A4 (de) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science Arzneiabgabesystem mit magenretention, herstellungsverfahren und anwendung
JP2012505203A (ja) 2008-10-08 2012-03-01 バイオプラス ライフ サイエンスズ ピーヴイティ リミテッド 持続放出性薬剤送達システム
EP2283824B1 (de) 2009-07-30 2017-04-19 Special Products Line S.p.A. Zusammensetzungen und Formulierungen, die auf quellbaren Matrizen basieren, zur verzögerten Freisetzung von schlecht löslichen Arzneimitteln, wie zum Beispiel Clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
WO2014144661A1 (en) * 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
EP3468382A4 (de) * 2016-06-14 2020-01-22 Prevtec Microbia Inc Tierfutterpellets mit futtermittelzusatz, verfahren zur herstellung und verwendung davon
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
WO2018232413A1 (en) 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
JP7048770B2 (ja) 2018-06-18 2022-04-05 アムニール コンプレックス プロダクツ リサーチ エルエルシー ピリドスチグミンを含む持続放出組成物
JP7034343B2 (ja) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3909520A1 (de) * 1988-03-25 1989-10-05 Ciba Geigy Ag Feste, schnell zerfallende darreichungsformen
WO1993013760A1 (de) * 1992-01-13 1993-07-22 Gerhard Gergely Pharmazeutische zubereitung in form einer brause- und/oder zerfallstablette oder eines instantgranulats, sowie verfahren zu ihrer herstellung
GB2283172A (en) * 1993-10-29 1995-05-03 Scherer Ltd R P Gelatin capsules
EP0667151A1 (de) * 1994-02-08 1995-08-16 Hexal Pharma GmbH Orale Arzeimittelzubereitung mit Diclofenac-Natrium
WO1996008238A1 (en) * 1994-09-14 1996-03-21 Glaxo Group Limited Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
WO1998032425A1 (en) * 1997-01-29 1998-07-30 Poli Industria Chimica S.P.A. Pharmaceutical formulations with delayed drug release
WO1999004765A2 (en) * 1997-07-23 1999-02-04 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
WO1991006281A1 (en) * 1989-10-26 1991-05-16 Nippon Shinyaku Co., Ltd. Gastric preparation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3909520A1 (de) * 1988-03-25 1989-10-05 Ciba Geigy Ag Feste, schnell zerfallende darreichungsformen
WO1993013760A1 (de) * 1992-01-13 1993-07-22 Gerhard Gergely Pharmazeutische zubereitung in form einer brause- und/oder zerfallstablette oder eines instantgranulats, sowie verfahren zu ihrer herstellung
GB2283172A (en) * 1993-10-29 1995-05-03 Scherer Ltd R P Gelatin capsules
EP0667151A1 (de) * 1994-02-08 1995-08-16 Hexal Pharma GmbH Orale Arzeimittelzubereitung mit Diclofenac-Natrium
WO1996008238A1 (en) * 1994-09-14 1996-03-21 Glaxo Group Limited Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
WO1998032425A1 (en) * 1997-01-29 1998-07-30 Poli Industria Chimica S.P.A. Pharmaceutical formulations with delayed drug release
WO1999004765A2 (en) * 1997-07-23 1999-02-04 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0110419A1 *

Also Published As

Publication number Publication date
AP2002002410A0 (en) 2002-03-31
OA12003A (en) 2006-04-18
WO2001010405A1 (en) 2001-02-15
CA2378468A1 (en) 2001-02-15
AU774957B2 (en) 2004-07-15
SK1832002A3 (en) 2002-08-06
AU5060499A (en) 2001-03-05
WO2001010419A1 (en) 2001-02-15
EA200200126A1 (ru) 2002-10-31
JP2003506400A (ja) 2003-02-18
NZ516959A (en) 2003-10-31
TR200200467T2 (tr) 2002-08-21
EP1206249A1 (de) 2002-05-22
CZ2002415A3 (cs) 2002-08-14
HUP0202497A3 (en) 2004-05-28
CN1376059A (zh) 2002-10-23
HK1047226A1 (zh) 2003-02-14
AU6309900A (en) 2001-03-05
IL147966A0 (en) 2002-09-12
MXPA02001272A (es) 2002-07-22
PL353321A1 (en) 2003-11-17
HUP0202497A2 (hu) 2002-11-28
BR0012981A (pt) 2002-06-18
ZA200200926B (en) 2002-11-27
HRP20020108A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
IL147966A0 (en) Hydrodynamically balancing oral drug delivery system
GB9904629D0 (en) Oral drug delivery system
HK1072177A1 (en) Drug delivery device
AU7333601A (en) Drug delivery management system
AU2123200A (en) Drug delivery device
AU2002302890A1 (en) Hydrodynamically balancing oral drug delivery system with biphasic release
EP1061987A4 (de) Vorrichtung zum verabreichen eines medikamentes
AU3520900A (en) Implantable drug delivery system
EP1087753A4 (de) Zielgerichtetes liposomales arzneistoffverabreichungssystem
EP0989878A4 (de) Arzneimittelverabreichungssystem
EP1021137A4 (de) Anordnung zur medikamentenzuführung
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
GB0029843D0 (en) Drug delivery system
GB9930160D0 (en) Drug delivery
GB9914960D0 (en) Delivery system
AU2002210580A1 (en) Drug delivery system
GB9901133D0 (en) Drug delivery system
GB9902509D0 (en) Drug delivery system
GB9923273D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB9905134D0 (en) Medicament delivery system
GB9800835D0 (en) Drug delivery system
AU4808000A (en) Drug delivery system
GB9904304D0 (en) Drug delivery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020304

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20020304

A4 Supplementary search report drawn up and despatched

Effective date: 20041109

17Q First examination report despatched

Effective date: 20061211

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1047226

Country of ref document: HK